Neuroprotective strategies involving ROS in Alzheimer disease
- PMID: 21130159
- PMCID: PMC3070183
- DOI: 10.1016/j.freeradbiomed.2010.11.026
Neuroprotective strategies involving ROS in Alzheimer disease
Abstract
Alzheimer disease (AD) is a neurodegenerative disorder in which oxidative stress is a key hallmark. It occurs early in disease pathogenesis and can exacerbate its progression. Several causes of oxidative stress have been determined over the years. First, mitochondria play an important role in the generation and accumulation of free radicals. In addition to mitochondria, inflammation can also induce oxidative damage, especially via microglia, and microglia are also important for Aβ clearance. In AD, both mitochondrial function and inflammatory response are affected, leading to increased ROS formation and oxidative damage to lipid, proteins, and nucleic acids. Some other sources have also been identified. From these findings, various neuroprotective strategies against ROS-mediated damages have been elaborated in AD research. This review recapitulates some of the major strategies used to prevent oxidative stress and disease progression. Outcomes from in vitro and in vivo studies using models of AD are encouraging. However, only a few clinical trials have provided positive results in terms of slowing down cognitive decline. Nonetheless, there is still hope for improved compounds that would better target pathways implicated in ROS production. In fact, facilitating the endogenous antioxidant system by modulating transcription has great promise for AD therapy.
Published by Elsevier Inc.
Figures





Similar articles
-
Delineation of Neuroprotective Effects and Possible Benefits of AntioxidantsTherapy for the Treatment of Alzheimer's Diseases by Targeting Mitochondrial-Derived Reactive Oxygen Species: Bench to Bedside.Mol Neurobiol. 2022 Jan;59(1):657-680. doi: 10.1007/s12035-021-02617-1. Epub 2021 Nov 9. Mol Neurobiol. 2022. PMID: 34751889 Review.
-
Mitochondria-targeted peptide antioxidants: novel neuroprotective agents.AAPS J. 2006 Aug 18;8(3):E521-31. doi: 10.1208/aapsj080362. AAPS J. 2006. PMID: 17025271 Free PMC article. Review.
-
Antioxidant pathways in Alzheimer's disease: possibilities of intervention.Curr Pharm Des. 2011 Dec;17(35):3861-4. doi: 10.2174/138161211798357755. Curr Pharm Des. 2011. PMID: 21933145 Review.
-
Mitochondria-targeting Cu2-xSe-TPP with dual enzyme activity alleviates Alzheimer's disease by modulating oxidative stress.Colloids Surf B Biointerfaces. 2025 Jan;245:114244. doi: 10.1016/j.colsurfb.2024.114244. Epub 2024 Sep 27. Colloids Surf B Biointerfaces. 2025. PMID: 39366108
-
Platycodon grandiflorum root extract inhibits Aβ deposition by breaking the vicious circle linking oxidative stress and neuroinflammation in Alzheimer's disease.Biomed Pharmacother. 2024 Aug;177:117090. doi: 10.1016/j.biopha.2024.117090. Epub 2024 Jul 4. Biomed Pharmacother. 2024. PMID: 38968796
Cited by
-
Neuro-Preventive Effect and Elevation of Cellular Adenosine Triphosphate by PUFAs from Pteleiosis suberosa Stem Bark on Mercury Sub-Acute Exposed Rats.J Acute Med. 2017 Mar 1;7(1):1-9. doi: 10.6705/j.jacme.2017.0701.001. J Acute Med. 2017. PMID: 32995163 Free PMC article.
-
Antiamnesic and Antioxidants Effects of Ferulago angulata Essential Oil Against Scopolamine-Induced Memory Impairment in Laboratory Rats.Neurochem Res. 2015 Sep;40(9):1799-809. doi: 10.1007/s11064-015-1662-6. Epub 2015 Jul 14. Neurochem Res. 2015. PMID: 26168780
-
Oxidative stress in Alzheimer's and Parkinson's diseases: insights from the yeast Saccharomyces cerevisiae.Oxid Med Cell Longev. 2012;2012:132146. doi: 10.1155/2012/132146. Epub 2012 Jun 3. Oxid Med Cell Longev. 2012. PMID: 22701754 Free PMC article. Review.
-
Preclinical Evidence and Possible Mechanisms of Extracts or Compounds from Cistanches for Alzheimer's Disease.Aging Dis. 2019 Oct 1;10(5):1075-1093. doi: 10.14336/AD.2018.0815-1. eCollection 2019 Oct. Aging Dis. 2019. PMID: 31595204 Free PMC article. Review.
-
Effects of Donepezil Hydrochloride on Neuronal Response of Pyramidal Neurons of the CA1 Hippocampus in Rat Model of Alzheimer's Disease.Basic Clin Neurosci. 2019 Mar-Apr;10(2):109-117. doi: 10.32598/bcn.9.10.305. Epub 2019 Mar 1. Basic Clin Neurosci. 2019. PMID: 31031898 Free PMC article.
References
-
- Nunomura A, Castellani RJ, Zhu X, Moreira PI, Perry G, Smith MA. Involvement of oxidative stress in Alzheimer disease. J Neuropathol Exp Neurol. 2006;65:631–641. - PubMed
-
- Coppede F, Migliore L. DNA damage and repair in Alzheimer's disease. Curr Alzheimer Res. 2009;6:36–47. - PubMed
-
- Nunomura A, Moreira PI, Takeda A, Smith MA, Perry G. Oxidative RNA damage and neurodegeneration. Curr. Med. Chem. 2007;14:2968–2975. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical